|
|
Home sleep apnea testing compared to in-lab polysomnography for the evaluation of obstructive sleep apnea in children |
| 1R61HL162839-01 |
|
NHLBI |
2022 |
|
|
Treatment of Obstructive Sleep Apnea with Personalized Surgery in Children with Down Syndrome (TOPS-DS) |
| 1R61HL165345-01 |
|
NHLBI |
2022 |
|
|
Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea |
| 1R61HL165366-01 |
|
NHLBI |
2022 |
|
|
Positive Airway Pressure For The Treatment Of The Obstructive Sleep Apnea Syndrome In Children With Down Syndrome |
| 3R33HL151253-04S1 |
|
NHLBI |
2022 |
|
|
Medications for Obstructive Sleep Apnea to Improve Cognition in Children with Down Syndrome (MOSAIC DS) |
| 4R33HL151254-03 |
|
NHLBI |
2022 |
|
|
Neurocognitive Impairment in Acute Respiratory Failure and Shock: Understanding the Role of Neuronal Excitotoxicity |
| 5K23HL140482-05 |
|
NHLBI |
2022 |
|
|
Sleep health in special populations |
| 5K24HL143055-05 |
|
NHLBI |
2022 |
|
|
Mild intermittent hypoxia and CPAP: A multi-pronged approach to treat sleep apnea in intact and spinal cord injured humans |
| 5R01HL142757-04 |
|
NHLBI |
2022 |
|
|
Sleep-disordered breathing in infants with myelomeningocele |
| 5R01HL147261-03 |
|
NHLBI |
2022 |
|
|
Exploring the relationship between advanced multimodal brain MRI phenotypes, genes and cognitive outcome in adults with CHD |
| 5R01HL152358-02 |
|
NHLBI |
2022 |
